Company profile NVTA

Invitae Corp
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than... most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people. Show More
Quarter analysis & expected interestLast update: February 09 2024 01:28:55.

After 39 days of this quarter the interest is at 158.0. Based on that we can calculate that during remaining 52 days it will total up to 369.0.
invitea -stock -company expected interest is significantly higher compared to previous quarter (+60.4%) and same quarter last year (+93.2%).

YearQ1Q2Q3Q4
201961
182
198.4% QoQ
142
-22.0% QoQ
152
7.0% QoQ
2020 169
177.0% YoY 11.2% QoQ
141
-22.5% YoY -16.6% QoQ
156
9.9% YoY 10.6% QoQ
218
43.4% YoY 39.7% QoQ
2021 226
33.7% YoY 3.7% QoQ
258
83.0% YoY 14.2% QoQ
79
-49.4% YoY -69.4% QoQ
92
-57.8% YoY 16.5% QoQ
2022 208
-8.0% YoY 126.1% QoQ
243
-5.8% YoY 16.8% QoQ
167
111.4% YoY -31.3% QoQ
180
95.7% YoY 7.8% QoQ
2023 191
-8.2% YoY 6.1% QoQ
207
-14.8% YoY 8.4% QoQ
80
-52.1% YoY -61.4% QoQ
230
27.8% YoY 187.5% QoQ
2024 158
-17.3% YoY -31.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and invitea -stock -company search interestLast update: February 09 2024 01:28:54.
Correlation coefficient between keyword and revenue is 0.42
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 01:28:56.

The average 5 years interest of invitea -stock -company was 13.56 per week.
The last year interest of invitea -stock -company compared to the last 5 years has changed by 7.37%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 26.39%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NVTA
Company name: Invitae Corp
Sector: Health Care and Social Assistance
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-08-14T11:10:00-04:00

PR Newswire
Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

2024-02-21T08:59:54-05:00

SEC
25-NSE Form - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Invitae Corp (0001501134) (Subject)

2024-02-14T06:59:56-05:00

SEC
8-K Form - Current report, items 1.01, 1.03, 2.04, 7.01, 8.01, and 9.01 - Invitae Corp (0001501134) (Filer)

2024-02-13T17:07:58-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Invitae Corp (0001501134) (Subject)

2024-02-13T09:10:56-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Invitae Corp (0001501134) (Subject)

2024-02-06T17:07:32-05:00

SEC
8-K Form - Current report, item 3.01 - Invitae Corp (0001501134) (Filer)

2024-02-05T06:08:57-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Invitae Corp (0001501134) (Subject)

2024-01-30T07:00:00-05:00

PR Newswire
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

2024-01-29T16:01:01-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Invitae Corp (0001501134) (Subject)

2024-01-29T15:26:29-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Invitae Corp (0001501134) (Subject)

2024-01-24T16:34:13-05:00

SEC
8-K/A Form - [Amend] Current report, item 2.05 - Invitae Corp (0001501134) (Filer)

2024-01-22T07:05:11-05:00

SEC
8-K Form - Current report, items 1.01, 2.01, 2.05, 7.01, and 9.01 - Invitae Corp (0001501134) (Filer)

2024-01-22T07:00:00-05:00

PR Newswire
Invitae Completes Sale of Reproductive Health Assets to Natera

2024-01-22T12:00:00Z

BusinessWire
Natera Acquires Reproductive Health Assets from Invitae

2024-01-18T16:10:03-05:00

SEC
8-K Form - Current report, items 5.02 and 9.01 - Invitae Corp (0001501134) (Filer)